Prostate News Archive
16-Apr-2011
Prostate cancer screening higher in older, not middle-aged, men
prostate-cancer screening is at the center of a medical divide, with some medical experts saying men should be screened frequently and others saying too many are screened and that the false alarms aren?t worth the trouble. But both sides can agree on one thing: There?s little benefit in screening men with short life expectancies for what is often a slow-growing cancer. Does Prostate Cancer Screening Reduce Mortality Rates?
NEW YORK, April 14, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City , expressed concern today regarding the conclusions of a study published this month in the British Medical Journal ( BMJ ). Following a group of 9,000 men for 20 years; 1,500 of whom were screened for ... Prostate screenings don?t save lives: study
PROSTATE cancer screening does not save lives and are more trouble than they are worth, according to a report in the British Medical Journal. Prostate Cancer Canada Makes $1 Million Movember-Funded Leadership Gift to Support Edmonton's Campaign for Prostate ...
EDMONTON, Alberta -- /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ International Prostate Cancer Expert Dr. David Samadi Discusses Cardiac Drug Digoxin And Its Positive Effect On ...
According to a study by scientists at Johns Hopkins published in the April 3rd issue of Cancer Discover, a journal of the American Association for Cancer Research, men who used a cardiac drug called Digoxin had a 24 percent lower risk for prostate cancer. Digitalis, also called Digoxin, which is made from the foxglove plant, has been used for centuries in homeopathic medicine for congestive ...
Back to Prostate News Archive
